Cargando…
Group II metabotropic glutamate receptors modify N-methyl-D-aspartate receptors via Src kinase
Group II metabotropic glutamate receptors (mGluR2/3) have emerged as important targets for the treatment of schizophrenia. Since hypofunction of N-methyl-D-aspartate receptors (NMDARs) has also been implicated in the etiology of schizophrenia, we examined whether postsynaptic mGluR2/3 regulate NMDAR...
Autores principales: | Trepanier, Catherine, Lei, Gang, Xie, Yu-Feng, MacDonald, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558700/ https://www.ncbi.nlm.nih.gov/pubmed/23378895 http://dx.doi.org/10.1038/srep00926 |
Ejemplares similares
-
Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs
por: Muguruza, Carolina, et al.
Publicado: (2016) -
Group I Metabotropic Glutamate Receptors and Interacting Partners: An Update
por: Mao, Li-Min, et al.
Publicado: (2022) -
Optical Control of Metabotropic Glutamate Receptors
por: Levitz, Joshua, et al.
Publicado: (2013) -
Kinetic fingerprinting of metabotropic glutamate receptors
por: Kukaj, Taulant, et al.
Publicado: (2023) -
Biphasic Modulation of NMDA Receptor Function by Metabotropic Glutamate Receptors
por: O'Neill, Nathanael, et al.
Publicado: (2018)